The Deceptive Mask: Poorly Differentiated Sarcoma Masquerading as Disseminated Tuberculosis and Invasive Fungal Infection

Technical Summary: The Deceptive Mask of Poorly Differentiated Sarcoma

Problem Statement
In tuberculosis (TB)-endemic regions, the clinical presentation of bilateral pulmonary nodules accompanied by hemoptysis in young, immunocompetent patients typically triggers an immediate infectious workup. This case report addresses the diagnostic challenge posed by the convergence of three factors: trace-positive molecular results for Mycobacterium tuberculosis, positive fungal biomarkers, and radiological features classically associated with invasive fungal disease. The authors highlight the risk of "diagnostic anchoring," where clinicians rely on sensitive but non-specific biomarkers (such as trace GeneXpert Ultra results) to confirm an infectious etiology, potentially delaying the recognition of aggressive malignancies like poorly differentiated sarcoma.

Methodology
The paper presents a single case report of a 33-year-old immunocompetent male with occupational fiberglass exposure who presented with respiratory symptoms. The diagnostic methodology followed a stepwise clinical progression:

1. Initial Infectious Workup: Upon admission, the patient underwent flexible bronchoscopy with bronchoalveolar lavage (BAL). Results included a "very low" (trace) detection of M. tuberculosis via GeneXpert Ultra and a positive galactomannan assay (1.2).
2. Empirical Treatment: Based on these findings, the patient was treated with anti-tubercular therapy (ATT) and caspofungin.
3. Re-evaluation: When the patient failed to respond to maximal anti-infective therapy and clinical deterioration occurred, the team utilized advanced imaging and repeat testing. This included a second HRCT, PET-CT, and MRI brain.
4. Biopsy Strategy: A CT-guided biopsy of a lung nodule was initially attempted but yielded only necrosis and hemorrhage. Consequently, the team pivoted to a navigation-guided biopsy of accessible intracranial metastatic lesions to avoid the morbidity of an open-lung biopsy in a critically ill patient.
5. Histopathological and Immunohistochemical Analysis: The brain biopsy tissue was analyzed for cellular morphology and proliferative index to establish a definitive diagnosis.

Key Results

• Diagnostic Discrepancy: The initial trace-positive GeneXpert result and positive BAL galactomannan were not corroborated by repeat testing (subsequent BAL was negative for MTB; serum galactomannan became negative).
• Radiological Findings: While the initial HRCT showed features suggestive of invasive fungal disease (centrilobular nodules with a halo sign), the PET-CT revealed a massive (75 × 95 × 82 mm) FDG-avid mediastinal mass and FDG-avid intracranial lesions.
• Clinical Markers: Upon readmission, the patient exhibited a markedly elevated D-dimer, falling hemoglobin, and a very low procalcitonin level (0.07 ng/mL), which the authors note pointed away from infection and toward a pro-malignant or pro-thrombotic state.
• Definitive Diagnosis: Histopathology of the brain biopsy confirmed poorly differentiated sarcoma, characterized by pleomorphic malignant cells, hyperchromatic nuclei, and a high proliferative index.
• Outcome: The patient was started on palliative chemotherapy (Paclitaxel) but developed florid Tumor Lysis Syndrome (TLS) after the first dose. The patient succumbed to septic shock, Type 1 respiratory failure, and TLS six weeks after initial presentation.

Key Contributions
The paper contributes to clinical practice by illustrating specific diagnostic pitfalls and procedural strategies:

• Interpretation of Trace Biomarkers: It demonstrates that a single trace-positive molecular result for TB, especially when not replicated on repeat testing and lacking corroborative microbiological evidence, should not anchor a diagnosis of infection, particularly in the absence of response to therapy.
• Radiological Mimicry: The case confirms that the "halo sign," often considered pathognomonic for angio-invasive aspergillosis in immunocompromised hosts, can also occur in hemorrhagic pulmonary metastases from sarcomas.
• Biopsy Site Selection: The authors propose a transferable lesson regarding biopsy strategy: when a primary lesion (lung nodule) yields only necrosis, targeting accessible metastatic sites (in this case, brain lesions) via navigation-guided biopsy can be safer and more diagnostically productive than repeated attempts on the primary site or invasive open surgery.
• TLS Risk in Bulky Disease: The case underscores the necessity of anticipatory prophylaxis for Tumor Lysis Syndrome when initiating chemotherapy in patients with high tumor burden solid tumors.

Significance and Claims
The paper claims that the convergence of trace infectious biomarkers and classical radiological patterns can create a "deceptive mask" that leads to fatal delays in diagnosing aggressive malignancies. The authors emphasize that in TB-endemic settings, vigilance for malignancy must be maintained even when infectious markers appear confirmatory. The significance of the report lies in its warning against over-reliance on sensitive molecular assays without histological confirmation and its advocacy for re-evaluating the diagnostic pathway when a patient fails to respond to standard anti-infective regimens. The authors conclude that biopsy of accessible metastatic deposits offers a critical, often safer, route to definitive diagnosis when primary biopsies are non-diagnostic.